| Name | Crenezumab |
|---|
| Description | Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |